FindTrial
Sign In

Relationship between the Administration of Tolvaptan and Rehospitalization in Patients with a History of Hospitalization Due to Heart Failure -A retrospective cohort study conducted using a DPC database -

Relationship between the Administration of Tolvaptan and Rehospitalization in Patients with a History of Hospitalization Due to Heart Failure -A retrospective cohort study conducted using a DPC database - - Relationship between the Administration of Tolvaptan and Rehospitalization in Patients with a History of Hospitalization Due to Heart Failure -A retrospective cohort study conducted using a DPC database -

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000029431
Enrollment
2000
Registered
2017-10-06
Start date
2017-10-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

None listed

Sponsors

Hyogo Prefectural Amagasaki General Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients in the medical facility which obtain the information of in/out patients data continuously least 24 months, were hospitalized least two times during the period from April 1, 2008 through March 31, 2017 due to HF (ICD 10; I11.0, I13.0, I13.2, I50) and were continuously administered any of the diuretics (1st cohort).

Exclusion criteria

Exclusion criteria: Patients who were aged less than 20 years at the time of the Index date Patients who were not prescribed a diuretic within 30 days after the Index date Patients who received dialysis (medical treatment of classification No. J038, and J042 by qualified medical personal) within 30 days after the Index date Patients where the Index date is March 2, 2017 or late Patients with no NYHA classified data within 1 year before the Index date Patients who were diagnosed with acute or recurrent myocardial infarction (ICD 10; I2[12]), and unstable angina (ICD 10; I200) within 30 days before the Index date Patients who were diagnosed with malignant neoplasm (ICD 10; C), liver failure (K704, K72), or an infectious disease with a poor prognosis such as HIV (ICD 10; B2 [01234]) within 1800 days before the Index date. Patients who were rehospitalized due to HF within 30 days after the Index date

Design outcomes

Primary

MeasureTime frame
Period until first rehospitalization due to HF after the index date in the Case 1 group and the matched Hcont group and Scont group.—

Secondary

MeasureTime frame
The period until first rehospitalization due to HF after the Index date in the Case 2 group and the matched Hcont group and Scont group. The period until first all cause rehospitalization after the index date in the Case 1 and Case 2 group and respective matched Hcont and Scont group.—

Countries

Japan

Contacts

Public ContactKoji Shimamoto

MediStatLab Co., Ltd. Head Office

skoji@medistatlab.com03-6659-7350

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026